These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 11532942

  • 21. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y.
    Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064
    [Abstract] [Full Text] [Related]

  • 22. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R.
    Br J Cancer; 2000 Nov 15; 83(10):1387-93. PubMed ID: 11044366
    [Abstract] [Full Text] [Related]

  • 23. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
    Benyon RC, Hovell CJ, Da Gaça M, Jones EH, Iredale JP, Arthur MJ.
    Hepatology; 1999 Oct 15; 30(4):977-86. PubMed ID: 10498650
    [Abstract] [Full Text] [Related]

  • 24. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J, Pei D.
    Cancer Res; 2003 Oct 15; 63(20):6758-62. PubMed ID: 14583471
    [Abstract] [Full Text] [Related]

  • 25. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
    Wang F, Reierstad S, Fishman DA.
    Cancer Lett; 2006 May 18; 236(2):292-301. PubMed ID: 16019136
    [Abstract] [Full Text] [Related]

  • 26. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
    Suenaga N, Mori H, Itoh Y, Seiki M.
    Oncogene; 2005 Jan 27; 24(5):859-68. PubMed ID: 15558018
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW.
    Lab Invest; 1997 May 27; 76(5):651-60. PubMed ID: 9166284
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y, Miyamori H, Thompson EW, Takino T, Endo Y, Sato H.
    Cancer Res; 2008 Nov 01; 68(21):9096-104. PubMed ID: 18974156
    [Abstract] [Full Text] [Related]

  • 33. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA, Bafetti LM, Stack MS.
    Invasion Metastasis; 1996 Nov 01; 16(3):150-9. PubMed ID: 9186550
    [Abstract] [Full Text] [Related]

  • 34. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
    Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M.
    EMBO J; 2002 Aug 01; 21(15):3949-59. PubMed ID: 12145196
    [Abstract] [Full Text] [Related]

  • 35. Integrin cleavage facilitates cell surface-associated proteolysis required for vascular smooth muscle cell invasion.
    Kappert K, Meyborg H, Baumann B, Furundzija V, Kaufmann J, Graf K, Stibenz D, Fleck E, Stawowy P.
    Int J Biochem Cell Biol; 2009 Jul 01; 41(7):1511-7. PubMed ID: 19166965
    [Abstract] [Full Text] [Related]

  • 36. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
    Maquoi E, Frankenne F, Noël A, Krell HW, Grams F, Foidart JM.
    Exp Cell Res; 2000 Dec 15; 261(2):348-59. PubMed ID: 11112341
    [Abstract] [Full Text] [Related]

  • 37. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M, Thomas LE, Wheeler SE, Curry TE.
    Biol Reprod; 2004 Apr 15; 70(4):1024-32. PubMed ID: 14668206
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS.
    Lab Invest; 2004 Jan 15; 84(1):8-20. PubMed ID: 14631378
    [Abstract] [Full Text] [Related]

  • 40. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA.
    Cancer Res; 2001 Aug 15; 61(16):6264-75. PubMed ID: 11507081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.